Glucosamine
Brand names: Alateris
Glucosamine is a supplement marketed for symptomatic relief of osteoarthritis, particularly of the knee.
Use as directed by the product's instructions, and check your local formulary.
Clinical monograph
How it works
It is a naturally occurring amino sugar involved in cartilage matrix synthesis, though its precise clinical mechanism in osteoarthritis is not fully established.
Prescribing in practice
- Evidence for clinically meaningful benefit is limited and inconsistent, and NICE does not recommend it for osteoarthritis management.
- Some products are derived from shellfish, so caution is advised in patients with shellfish allergy.
- It may theoretically interact with anticoagulants, so review patients on warfarin.
Monitoring
No specific monitoring is required, but review symptomatic response and discontinue if no benefit is observed.
Counselling the patient
- This is a supplement and may not improve your joint symptoms.
- Check the product source if you have a shellfish allergy.
- Tell your clinician you are taking it if you are on blood-thinning medication.
Evidence & guidelines
NICE guidance on osteoarthritis does not recommend glucosamine because evidence of benefit is insufficient.
Reference: NICE NG226 (osteoarthritis); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022